HEADER IMMUNE SYSTEM 20-AUG-12 4B7I TITLE CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C REGION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: IMMUNOGLOBULIN GAMMA, FC, RESIDUES 120-329; COMPND 5 SYNONYM: IGG1 FC; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 9 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1573; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PHLSEC KEYWDS IMMUNE SYSTEM, IGG, ANTIBODY, SWAINSONINE, HYBRID EXPDTA X-RAY DIFFRACTION AUTHOR T.A.BOWDEN,K.BARUAH,C.H.COLES,D.J.HARVEY,B.D.SONG,D.I.STUART, AUTHOR 2 A.R.ARICESCU,C.N.SCANLAN,E.Y.JONES,M.CRISPIN REVDAT 6 13-NOV-24 4B7I 1 REMARK REVDAT 5 20-DEC-23 4B7I 1 HETSYN LINK REVDAT 4 29-JUL-20 4B7I 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 03-APR-19 4B7I 1 SOURCE LINK REVDAT 2 07-NOV-12 4B7I 1 JRNL REVDAT 1 17-OCT-12 4B7I 0 JRNL AUTH T.A.BOWDEN,K.BARUAH,C.H.COLES,D.J.HARVEY,X.YU,B.D.SONG, JRNL AUTH 2 D.I.STUART,A.R.ARICESCU,C.N.SCANLAN,E.Y.JONES,M.CRISPIN JRNL TITL CHEMICAL AND STRUCTURAL ANALYSIS OF AN ANTIBODY FOLDING JRNL TITL 2 INTERMEDIATE TRAPPED DURING GLYCAN BIOSYNTHESIS. JRNL REF J.AM.CHEM.SOC. V. 134 17554 2012 JRNL REFN ISSN 0002-7863 JRNL PMID 23025485 JRNL DOI 10.1021/JA306068G REMARK 2 REMARK 2 RESOLUTION. 2.36 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.36 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 20296 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1083 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.36 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.42 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1459 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.32 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 65 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3183 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.39000 REMARK 3 B22 (A**2) : -2.17000 REMARK 3 B33 (A**2) : 5.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.386 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.266 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.207 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.470 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3374 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3137 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4599 ; 1.161 ; 1.990 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7262 ; 0.852 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 393 ; 5.706 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 143 ;35.760 ;24.825 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 555 ;15.040 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;13.444 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 529 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3633 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 715 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 237 A 339 REMARK 3 ORIGIN FOR THE GROUP (A): -17.3219 -10.1942 -10.5022 REMARK 3 T TENSOR REMARK 3 T11: 0.1907 T22: 0.1812 REMARK 3 T33: 0.0289 T12: -0.0063 REMARK 3 T13: -0.0163 T23: 0.0262 REMARK 3 L TENSOR REMARK 3 L11: 0.6608 L22: 0.2458 REMARK 3 L33: 1.1763 L12: -0.2121 REMARK 3 L13: 0.3259 L23: -0.4631 REMARK 3 S TENSOR REMARK 3 S11: 0.0026 S12: -0.0784 S13: 0.0008 REMARK 3 S21: 0.0414 S22: 0.0217 S23: 0.0334 REMARK 3 S31: 0.0174 S32: -0.0522 S33: -0.0243 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 340 A 353 REMARK 3 ORIGIN FOR THE GROUP (A): -12.6868 6.0561 -37.7157 REMARK 3 T TENSOR REMARK 3 T11: 0.0952 T22: 0.1590 REMARK 3 T33: 0.0790 T12: -0.0152 REMARK 3 T13: -0.0240 T23: 0.0258 REMARK 3 L TENSOR REMARK 3 L11: 4.4529 L22: 1.3703 REMARK 3 L33: 3.9966 L12: -0.5708 REMARK 3 L13: -3.7043 L23: 0.8323 REMARK 3 S TENSOR REMARK 3 S11: 0.0591 S12: 0.2556 S13: 0.0401 REMARK 3 S21: -0.0745 S22: 0.0401 S23: 0.1580 REMARK 3 S31: -0.1716 S32: -0.1686 S33: -0.0992 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 354 A 444 REMARK 3 ORIGIN FOR THE GROUP (A): -3.8627 -1.2891 -40.7609 REMARK 3 T TENSOR REMARK 3 T11: 0.1352 T22: 0.1804 REMARK 3 T33: 0.1287 T12: -0.0065 REMARK 3 T13: 0.0025 T23: -0.0212 REMARK 3 L TENSOR REMARK 3 L11: 1.5987 L22: 0.7760 REMARK 3 L33: 0.0687 L12: 1.0329 REMARK 3 L13: -0.0536 L23: -0.0839 REMARK 3 S TENSOR REMARK 3 S11: -0.0937 S12: 0.0302 S13: -0.2571 REMARK 3 S21: -0.0865 S22: 0.1028 S23: -0.1064 REMARK 3 S31: 0.0097 S32: 0.0011 S33: -0.0091 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 238 B 287 REMARK 3 ORIGIN FOR THE GROUP (A): 17.6934 22.6451 -15.2995 REMARK 3 T TENSOR REMARK 3 T11: 0.3581 T22: 0.1330 REMARK 3 T33: 0.0667 T12: 0.0451 REMARK 3 T13: 0.0006 T23: 0.0050 REMARK 3 L TENSOR REMARK 3 L11: 1.0855 L22: 4.4902 REMARK 3 L33: 1.8152 L12: -1.6240 REMARK 3 L13: -0.5078 L23: -1.0295 REMARK 3 S TENSOR REMARK 3 S11: -0.3170 S12: -0.0190 S13: -0.0890 REMARK 3 S21: 0.9255 S22: 0.2073 S23: 0.0836 REMARK 3 S31: -0.2306 S32: -0.0856 S33: 0.1097 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 288 B 340 REMARK 3 ORIGIN FOR THE GROUP (A): 17.9672 21.6674 -12.6485 REMARK 3 T TENSOR REMARK 3 T11: 0.4493 T22: 0.2660 REMARK 3 T33: 0.0982 T12: 0.0061 REMARK 3 T13: -0.1055 T23: 0.0962 REMARK 3 L TENSOR REMARK 3 L11: 3.0557 L22: 2.9419 REMARK 3 L33: 0.7906 L12: -1.7528 REMARK 3 L13: -1.1207 L23: -0.1908 REMARK 3 S TENSOR REMARK 3 S11: -0.3146 S12: -0.5194 S13: -0.3183 REMARK 3 S21: 0.9300 S22: 0.0342 S23: -0.1708 REMARK 3 S31: -0.1746 S32: 0.3638 S33: 0.2805 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 341 B 444 REMARK 3 ORIGIN FOR THE GROUP (A): 5.0039 12.7859 -40.9686 REMARK 3 T TENSOR REMARK 3 T11: 0.1306 T22: 0.1688 REMARK 3 T33: 0.0577 T12: -0.0141 REMARK 3 T13: -0.0114 T23: 0.0097 REMARK 3 L TENSOR REMARK 3 L11: 2.7515 L22: 0.9677 REMARK 3 L33: 0.2523 L12: 0.1091 REMARK 3 L13: 0.3989 L23: -0.4127 REMARK 3 S TENSOR REMARK 3 S11: -0.1097 S12: 0.0274 S13: 0.1131 REMARK 3 S21: -0.0844 S22: 0.0809 S23: 0.0111 REMARK 3 S31: 0.0133 S32: -0.0323 S33: 0.0288 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. T393A MUTATION AROSE DURING CLONING REMARK 4 REMARK 4 4B7I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1290053760. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 77.2 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : SINGLE SILICON (111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21447 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.360 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.36 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3AVE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% W/V PEG 3350 PH 5.5, 0.2 M REMARK 280 SODIUM/POTASSIUM PHOSPHATE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.52050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.41650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.49550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.41650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.52050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.49550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 20.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 445 REMARK 465 GLY A 446 REMARK 465 THR A 447 REMARK 465 LYS A 448 REMARK 465 HIS A 449 REMARK 465 HIS A 450 REMARK 465 HIS A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 GLY B 237 REMARK 465 VAL B 266 REMARK 465 SER B 267 REMARK 465 HIS B 268 REMARK 465 GLU B 269 REMARK 465 ASP B 270 REMARK 465 PRO B 271 REMARK 465 GLU B 272 REMARK 465 GLU B 294 REMARK 465 GLN B 295 REMARK 465 TYR B 296 REMARK 465 ASN B 297 REMARK 465 VAL B 323 REMARK 465 SER B 324 REMARK 465 ASN B 325 REMARK 465 LYS B 326 REMARK 465 ALA B 327 REMARK 465 LEU B 328 REMARK 465 PRO B 445 REMARK 465 GLY B 446 REMARK 465 THR B 447 REMARK 465 LYS B 448 REMARK 465 HIS B 449 REMARK 465 HIS B 450 REMARK 465 HIS B 451 REMARK 465 HIS B 452 REMARK 465 HIS B 453 REMARK 465 HIS B 454 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 297 31.69 -98.01 REMARK 500 ASN B 390 69.46 70.29 REMARK 500 ASN B 434 13.84 59.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2094 DISTANCE = 6.22 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AJ7 RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5- REMARK 900 (PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION REMARK 900 OF AN ESTEROLYTIC ANTIBODY REMARK 900 RELATED ID: 1AQK RELATED DB: PDB REMARK 900 THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR REMARK 900 TETANUS TOXOID REMARK 900 RELATED ID: 1BEY RELATED DB: PDB REMARK 900 ANTIBODY TO CAMPATH-1H HUMANIZED FAB REMARK 900 RELATED ID: 1D5B RELATED DB: PDB REMARK 900 UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1D5I RELATED DB: PDB REMARK 900 UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1D6V RELATED DB: PDB REMARK 900 CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE REMARK 900 ANTIBODY MATURATION REMARK 900 RELATED ID: 1DN2 RELATED DB: PDB REMARK 900 FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE REMARK 900 PEPTIDE DCAWHLGELVWCT-NH2 REMARK 900 RELATED ID: 1E4K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC -GAMMA REMARK 900 RECEPTOR III COMPLEX REMARK 900 RELATED ID: 1FC1 RELATED DB: PDB REMARK 900 FC FRAGMENT (IGG1 CLASS) REMARK 900 RELATED ID: 1FC2 RELATED DB: PDB REMARK 900 RELATED ID: 1FCC RELATED DB: PDB REMARK 900 RELATED ID: 1H3T RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3U RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3V RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3W RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALTCONDITION REMARK 900 RELATED ID: 1I7Z RELATED DB: PDB REMARK 900 ANTIBODY GNC92H2 BOUND TO LIGAND REMARK 900 RELATED ID: 1L6X RELATED DB: PDB REMARK 900 FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OFTHE B- REMARK 900 DOMAIN FROM PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1OQX RELATED DB: PDB REMARK 900 G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSIONOF REMARK 900 PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1T83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR INCOMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC) REMARK 900 RELATED ID: 1T89 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR INCOMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL) REMARK 900 RELATED ID: 2IWG RELATED DB: PDB REMARK 900 COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC REMARK 900 RELATED ID: 2J6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM REMARK 900 RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND REMARK 900 EVIDENCE FOR AFFINITY MATURATION REMARK 900 RELATED ID: 2RCS RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB - AFFINITY MATURATION OF AN REMARK 900 ESTEROLYTIC ANTIBODY REMARK 900 RELATED ID: 2WAH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2) REMARK 900 RELATED ID: 4ACP RELATED DB: PDB REMARK 900 DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT DBREF 4B7I A 237 446 UNP P01857 IGHG1_HUMAN 120 329 DBREF 4B7I B 237 446 UNP P01857 IGHG1_HUMAN 120 329 SEQADV 4B7I THR A 447 UNP P01857 EXPRESSION TAG SEQADV 4B7I LYS A 448 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS A 449 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS A 450 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS A 451 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS A 452 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS A 453 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS A 454 UNP P01857 EXPRESSION TAG SEQADV 4B7I ALA A 393 UNP P01857 THR 276 CLONING ARTIFACT SEQADV 4B7I THR B 447 UNP P01857 EXPRESSION TAG SEQADV 4B7I LYS B 448 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS B 449 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS B 450 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS B 451 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS B 452 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS B 453 UNP P01857 EXPRESSION TAG SEQADV 4B7I HIS B 454 UNP P01857 EXPRESSION TAG SEQADV 4B7I ALA B 393 UNP P01857 THR 276 CLONING ARTIFACT SEQRES 1 A 218 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 2 A 218 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 3 A 218 VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE SEQRES 4 A 218 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 5 A 218 THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG SEQRES 6 A 218 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 7 A 218 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA SEQRES 8 A 218 LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 9 A 218 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SEQRES 10 A 218 SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU THR SEQRES 11 A 218 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 12 A 218 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 13 A 218 ALA THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE SEQRES 14 A 218 LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 15 A 218 GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 16 A 218 LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER SEQRES 17 A 218 PRO GLY THR LYS HIS HIS HIS HIS HIS HIS SEQRES 1 B 218 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 2 B 218 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 3 B 218 VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE SEQRES 4 B 218 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 5 B 218 THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG SEQRES 6 B 218 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 7 B 218 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA SEQRES 8 B 218 LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 9 B 218 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SEQRES 10 B 218 SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU THR SEQRES 11 B 218 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 12 B 218 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 13 B 218 ALA THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE SEQRES 14 B 218 LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 15 B 218 GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 16 B 218 LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER SEQRES 17 B 218 PRO GLY THR LYS HIS HIS HIS HIS HIS HIS MODRES 4B7I ASN A 297 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET MAN C 6 11 HET MAN C 7 11 HET FUC C 8 10 HET CL B1445 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 3 MAN 4(C6 H12 O6) FORMUL 3 FUC C6 H12 O5 FORMUL 4 CL CL 1- FORMUL 5 HOH *218(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 SER A 354 LYS A 360 5 7 HELIX 4 4 LYS A 414 GLN A 419 1 6 HELIX 5 5 LEU A 432 TYR A 436 5 5 HELIX 6 6 LYS B 246 MET B 252 1 7 HELIX 7 7 LEU B 309 ASN B 315 1 7 HELIX 8 8 SER B 354 LYS B 360 5 7 HELIX 9 9 LYS B 414 GLN B 419 1 6 HELIX 10 10 LEU B 432 TYR B 436 5 5 SHEET 1 AA 4 SER A 239 PHE A 243 0 SHEET 2 AA 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 AA 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AA 4 GLU A 293 GLU A 294 1 O GLU A 293 N ARG A 301 SHEET 1 AB 4 SER A 239 PHE A 243 0 SHEET 2 AB 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 AB 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AB 4 LYS A 288 THR A 289 -1 O LYS A 288 N VAL A 305 SHEET 1 AC 2 GLU A 293 GLU A 294 0 SHEET 2 AC 2 TYR A 300 THR A 307 1 O ARG A 301 N GLU A 293 SHEET 1 AD 4 VAL A 282 VAL A 284 0 SHEET 2 AD 4 LYS A 274 VAL A 279 -1 O TRP A 277 N VAL A 284 SHEET 3 AD 4 TYR A 319 SER A 324 -1 O LYS A 320 N TYR A 278 SHEET 4 AD 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 AE 4 GLN A 347 LEU A 351 0 SHEET 2 AE 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AE 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AE 4 VAL A 397 LEU A 398 1 O VAL A 397 N PHE A 405 SHEET 1 AF 4 GLN A 347 LEU A 351 0 SHEET 2 AF 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AF 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AF 4 TYR A 391 ALA A 393 -1 O LYS A 392 N LYS A 409 SHEET 1 AG 2 VAL A 397 LEU A 398 0 SHEET 2 AG 2 PHE A 404 ASP A 413 1 O PHE A 405 N VAL A 397 SHEET 1 AH 4 GLN A 386 PRO A 387 0 SHEET 2 AH 4 ALA A 378 SER A 383 -1 O SER A 383 N GLN A 386 SHEET 3 AH 4 PHE A 423 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 4 AH 4 THR A 437 LEU A 441 -1 O THR A 437 N VAL A 427 SHEET 1 BA 4 SER B 239 PHE B 243 0 SHEET 2 BA 4 GLU B 258 VAL B 264 -1 O THR B 260 N PHE B 243 SHEET 3 BA 4 ARG B 301 THR B 307 -1 O VAL B 302 N VAL B 263 SHEET 4 BA 4 LYS B 288 THR B 289 -1 O LYS B 288 N VAL B 305 SHEET 1 BB 4 VAL B 282 VAL B 284 0 SHEET 2 BB 4 TRP B 277 VAL B 279 -1 O TRP B 277 N VAL B 284 SHEET 3 BB 4 TYR B 319 CYS B 321 -1 O LYS B 320 N TYR B 278 SHEET 4 BB 4 LYS B 334 ILE B 336 -1 O LYS B 334 N CYS B 321 SHEET 1 BC 4 GLN B 347 LEU B 351 0 SHEET 2 BC 4 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 BC 4 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BC 4 VAL B 397 LEU B 398 1 O VAL B 397 N PHE B 405 SHEET 1 BD 4 GLN B 347 LEU B 351 0 SHEET 2 BD 4 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 BD 4 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BD 4 TYR B 391 ALA B 393 -1 O LYS B 392 N LYS B 409 SHEET 1 BE 2 VAL B 397 LEU B 398 0 SHEET 2 BE 2 PHE B 404 ASP B 413 1 O PHE B 405 N VAL B 397 SHEET 1 BF 4 GLN B 386 PRO B 387 0 SHEET 2 BF 4 ALA B 378 SER B 383 -1 O SER B 383 N GLN B 386 SHEET 3 BF 4 PHE B 423 MET B 428 -1 O SER B 424 N GLU B 382 SHEET 4 BF 4 THR B 437 LEU B 441 -1 O THR B 437 N VAL B 427 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.01 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.04 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.03 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.04 LINK ND2 ASN A 297 C1 NAG C 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O6 NAG C 1 C1 FUC C 8 1555 1555 1.45 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.44 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.44 LINK O3 BMA C 3 C1 MAN C 7 1555 1555 1.45 LINK O3 MAN C 4 C1 MAN C 5 1555 1555 1.45 LINK O6 MAN C 4 C1 MAN C 6 1555 1555 1.44 CISPEP 1 TYR A 373 PRO A 374 0 -9.37 CISPEP 2 TYR B 373 PRO B 374 0 -7.41 CRYST1 49.041 72.991 140.833 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020391 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013700 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007101 0.00000